GL
Greenwich Lifesciences Inc
🇺🇸XNAS.GLSIUnited StatesHealthcare
$27.83USDup +0.63 (+2.32%)OpenEnd of day5:45 PM
Price$27.83+0.63 (+2.32%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US3968791083
- CUSIP
- 396879108
Company
- Employees
- 4
- Headquarters
- Stafford, United States
- CEO
- Mr. Snehal S. Patel
Market
- Shares outstanding
- 14.7M
- Market cap
- $385.57M
Highlights
- Market cap
- $385.57M
- EPS LTM
- -$1.48
- P/E LTM
- -18.77calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3.56K-1.5%down year on year
- Net income
- -$21.68M-24.04%down year on year
- Gross margin
- 50%+6,588.89%up year on year
- Free cash flow
- -$12.49M-46.86%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.